Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ONCY Stock Forecast, Price Targets, Chart, Dividends & Analysis

Oncolytics Biotech Inc. logo

Oncolytics Biotech Inc.

Sector: Healthcare   

Industry: Biotechnology

0.83
 
USD
  
-0.06
  
(-6.36%)
Previous close: 0.8874  Open: 0.87  Bid: 0.82  Ask: 0.83
52 week range    
0.71   
   1.53
Mkt Cap: 59 M  Avg Vol (90 Days): 531,409
Peers   
AEZS / 
LLY / 
BMY / 
TEVA / 
AVEO / 
MRTX / 
HBP-CA / 
Last updated: Sunday 22nd December 2024

Stock Rankings

46
Technical
21
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AEZS

0 B

AVEO

15

BMY

0.0433117 B1557.33

HBP-CA

LLY

0.0078739 B85.26767.76

MRTX

58.7

SPHS

TEVA

Financials

ONCY Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-19.0-10.83-11.78-10.83-1.06-1.5-0.56-0.49-0.43-0.41
Basic EPS total-19.0-10.83-11.78-10.83-1.06-1.5-0.56-0.49-0.43-0.41
Basic weighted shares outstanding973617.01 M1 M1 M16 M22 M40 M54 M58 M68 M
Depreciation392000.0
Depreciation unreconciled392000.0
DepreciationAndAmortization392000.0
DevelopmentExpense2 M
Diluted EPS total-19.0-10.83-11.78-10.83-1.06-1.5-0.56-0.49-0.43-0.41
Diluted normalized net income/share-19.0-10.83-11.78-10.83-1.06-1.5-0.56-0.49-0.43-0.41
Diluted weighted shares outstanding973617.01 M1 M1 M16 M22 M40 M54 M58 M68 M
GainOnSaleOfSecurity610106.0-13 M3 M-118519.0
GeneralAndAdministrativeExpense11 M16 M
Income before tax-19 M-14 M-15 M-15 M-16 M-33 M-23 M-26 M-28 M-28 M
Income taxes6779.03153.09374.0141498.0548042.049000.084000.097000.0
Interest income210390.0197859.0163902.0130101.0173496.0179277.0121194.098612.0528000.01 M
Net income from total operations-19 M-14 M-15 M-16 M-17 M-33 M-23 M-26 M-28 M-28 M
NetIncomeCommonStockholders-19 M-14 M-15 M-16 M-17 M-33 M-23 M-26 M-28 M-28 M
NetIncomeContinuousOperations-19 M-14 M-15 M-16 M-17 M-33 M-23 M-26 M-28 M-28 M
NetNonOperatingInterestIncomeExpense-210390.0-197859.0-163902.0-130101.0-173496.0-179277.0-121194.0-98612.0528000.01 M
Normalized income-14 M-10 M-11 M-11 M-12 M-24 M-17 M-19 M-21 M-20 M
Operating income-19 M-14 M-15 M-16 M-17 M-20 M-25 M-26 M-27 M-34 M
Operating income before depreciation (EBITDA)-18 M-14 M-15 M-15 M-16 M-33 M-25 M-26 M-27 M-27 M
OperatingExpense19 M14 M15 M16 M17 M20 M25 M26 M27 M34 M
Other income net610106.0-13 M3 M-118519.0-20000.05 M
OtherGandA11 M16 M
OtherOperatingExpenses5 M5 M6 M6 M7 M10 M13 M13 M112000.0
Research & development expense14 M9 M10 M9 M10 M11 M13 M13 M15 M18 M
ResearchExpense15 M18 M
SalariesAndWages8 M
Selling Gen & administrative expense11 M16 M
Total Income available for interest expense (EBIT)-19 M-14 M-15 M-15 M-16 M-33 M-25 M-26 M-27 M-28 M
Total common shares outstanding10 M12 M13 M15 M17 M26 M42 M55 M54 M
Total net income-19 M-14 M-15 M-16 M-17 M-33 M-23 M-26 M-28 M-28 M
Total ordinary shares77 M77 M77 M77 M77 M77 M77 M77 M77 M77 M
TotalExpenses-19 M-14 M-15 M-16 M-17 M-20 M-25 M-26 M27 M34 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University